Paul F Davis Selected Research

Paul F Davis Research Topics

Disease

16	Neoplasms (Cancer) 10/2021 - 01/2006
5	Hemangioma (Angioma) 01/2020 - 03/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
3	Keloid 01/2019 - 07/2016
2	Melanoma (Melanoma, Malignant) 10/2021 - 01/2006
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2019
2	Postpartum Depression (Post-Natal Depression) 08/2010 - 10/2008
1	Adenocarcinoma of Lung 10/2021
1	Carcinogenesis 10/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Neurilemmoma (Schwannoma) 11/2020
1	Brain Neoplasms (Brain Tumor) 10/2019
1	Inflammation (Inflammations) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Dupuytren Contracture (Dupuytrens Contracture) 02/2018
1	Fuchs' Endothelial Dystrophy 06/2016
1	Birth Weight (Birth Weights) 05/2016
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 05/2016
1	Hypoxia (Hypoxemia) 05/2016
1	Placental Insufficiency 05/2016
1	Pre-Eclampsia (Preeclampsia) 05/2016
1	Wounds and Injuries (Trauma) 09/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2011
1	1 Posterior Polymorphous Corneal Dystrophy 05/2009
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2006
1	Gliosis 04/2004
1	Cold Injury 04/2004
1	Fibrosis (Cirrhosis) 03/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2004
6	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2021 - 01/2017
4	CathepsinsIBA 10/2021 - 01/2015
4	3,3'-Diaminobenzidine (3,3 Diaminobenzidine)IBA 01/2019 - 01/2016
3	Formaldehyde (Formol)FDA Link 01/2019 - 01/2016
3	ParaffinIBA 01/2019 - 01/2016
3	Collagen Type VIIIIBA 06/2016 - 03/2004
2	Messenger RNA (mRNA)IBA 10/2021 - 11/2020
2	ReninIBA 11/2020 - 01/2015
2	CollagenIBA 01/2019 - 05/2009
2	Transcription Factor 4IBA 01/2018 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 01/2006
2	Docosahexaenoic AcidsIBA 08/2010 - 10/2008
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	AngiotensinogenIBA 01/2021
1	Cathepsin BIBA 01/2021
1	CateninsIBA 01/2021
1	Cathepsin GIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Kruppel-Like Factor 4IBA 01/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2016
1	NestinIBA 01/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2015
1	EnzymesIBA 01/2015
1	Angiotensin IIIBA 01/2015
1	Decellularized Extracellular MatrixIBA 09/2011
1	Biocompatible Materials (Biomaterials)IBA 09/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2010
1	A-factor (Streptomyces)IBA 10/2008
1	docosahexaenoylascorbic acid (DHA-As)IBA 10/2008
1	Interleukin-8 (Interleukin 8)IBA 01/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2006
1	Proteoglycans (Proteoglycan)IBA 01/2006
1	Peptide Hydrolases (Proteases)FDA Link 01/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2006
1	Chymases (Chymase)IBA 03/2004
1	Coloring Agents (Dyes)IBA 03/2004
1	ClusterinIBA 03/2004
1	Biogenic Amines (Biogenic Amine)IBA 03/2004
1	Tryptases (Tryptase)IBA 03/2004

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2019
1	Immunotherapy 01/2021
1	Adjuvant Chemoradiotherapy 10/2019